Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TSC-204-A0201 |
Synonyms | |
Therapy Description |
TSC-204-A0201 comprises autologous T-cells engineered to express a T-cell receptor (TCR) targeting the MAGE-A1 antigen presented on HLA-A*02:01, which potentially induce cytotoxic T-lymphocyte (CTL)-dependent killing of MAGE-A1-expressing tumor cells (NCI Drug Dictionary). |